Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis

Acta Dermato-Venereologica

Volumn 79, Issue 3, 1999, Pages 221-223

  Degreef, Hugo ^a,g   Palacio, Amalia Del ^e   Mygind, SØREN ^f   Ginter, Gabriele ^b   Soares, ANTÓNIO Pinto ^c   De Cadena, Angela Zuluaga ^d  

^a Departments of Dermatology   (Austria)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF GRAZ   (Austria)

^d Hospital do Desterro   (Portugal)

^e UNIVERSIDAD CES   (Colombia)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Antifungal agents; Dermatophytosis; Efficacy; Safety; Tolerability

Indexed keywords

ITRACONAZOLE; TERBINAFINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ONYCHOMYCOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; DOUBLE-BLIND METHOD; DYSPEPSIA; FEMALE; FOOT DERMATOSES; HEADACHE; HUMANS; ITRACONAZOLE; MALE; MIDDLE AGED; NAPHTHALENES; NAUSEA; ONYCHOMYCOSIS; TASTE DISORDERS; TREATMENT OUTCOME; TRICHOPHYTON; VIRUS DISEASES;

EID: 0032974954     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155599750011020     Document Type: Article

References (21)

1. 1. Grant SM, Clissold SP. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs 1989; 37: 310-344.
2. 2. Balfour JA, Faulds D. Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs 1992; 43: 259-284.
3. 3. Cauwenbergh G, Degreef H, Heykants J, Woestenborghs R, Van Rooy P, Haeverans K. Pharmacokinetic profile of orally administered itraconazole in human skin. J Am Acad Dermatol 1988; 18: 263-268.
4. 4. Matthieu L, De Doncker P, Cauwenbergh G, et al. Itraconazole penetrates the nail via the nail matrix and the nail bed - an investigation in onychomycosis. Clin Exp Dermatol 1991; 16: 374-376.
5. 5. Willemsen M, De Doncker P, Willems J, et al. Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis. J Am Acad Dermatol 1992; 26: 731-735.
6. 6. Faergemann J, Zehender H, Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days. Clin Exp Dermatol 1994; 19: 121-126.
7. 7. Dykes PJ, Thomas R, Finlay AY. Determination of terbinafine in nail samples during systemic treatment for onychomycoses. Br J Dermatol 1994; 123: 481-486.
8. 8. Haneke E, Deleseluse J, Plinck EPB, Hay RJ. The use of itraconazole in onychomycosis. Eur J Dermatol 1996; 6: 7-10.
9. 9. Goodfield MJD. Short-duration therapy with terbinafine for dermatophyte onychomycosis: a multicentre trial. Br J Dermatol 1992; 126: 33-35.
10. 10. Albanese G, Di Cintio R, Martini C, Nicoletti A. Short therapy for tinea unguium with terbinafine: four different courses of treatment. Mycoses 1995; 38: 211-214.
11. 11. Galimberti R, Kowalczuk A. Onychomycosis treated with a short course of oral terbinafine. Int J Dermatol 1996; 35: 374-375.
12. 12. Watson A, Marley J, Ellis D, Williams T. Terbinafine in onychomycosis of the toenail: a novel treatment protocol. J Am Acad Dermatol 1995; 33: 775-779.
13. 13. Blackwelder W. "Proving the null hypothesis" in clinical trials. Controlled Clin Trials 1982; 3: 345-353.
14. 14. Havu V, Brandt H, Heikkila H, et al. A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis. Br J Dermatol 1997; 136: 230-234.
15. 15. Arenas R, Dominguez-Cherit J. Open randomized comparison of itraconazole versus terbinafine in onychomycosis. Int J Dermatol 1995; 34: 138-143.
16. 16. Bräutigam M, Nolting S, Schopf RE, Weidinger G. Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. BMJ 1995; 311: 919-922.
17. 17. De Backer M, De Keyser P, De Vroey C, Lesaffre E. A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg/day vs. itraconazole 200 mg/day - a double-blind comparative trial. Br J Dermatol 1996; 134 (Suppl 46): 16-17.
18. 18. Samsoen M. Terbinafine (Lamisil): the first oral fungistatic and fungicidal allylamine. Nouv Dermatol 1992; 11: 743-762.
19. 19. Piérard GE, Arrese JE, De Doncker P. Antifungal activity of itraconazole and terbinafine in human stratum corneum: a comparative study. J Am Acad Dermatol 1995; 32: 429-435.
20. 20. De Beule K, Lubin G, Cauwenbergh G. Safety aspects of itraconazole therapy in vaginal candidosis, dermatomycosis and onychomycosis: a review. Curr Ther Res 1991; 49: 814-822.
21. 21. Goodfield MDJ, Rowell NR, Forster RA, Evans EGV, Raven A. Treatment of dermatophyte infection of the finger-and toe-nails with terbinafine. Br J Dermatol 1989; 121: 753-757.